EW — Edwards Lifesciences Share News
0.000.00%
Last trade - 00:00- $54.44bn
- $50.89bn
- $6.07bn
Corrected: Edwards Lifesciences scraps anti-copycat policy, EU drops antitrust investigation
Apple, Google again lose court challenge to US patent review policy (updated)
Apple, Google again lose court challenge to US patent review policy
U.S. RESEARCH ROUNDUP-Coca-Cola, Rapid7, Walmart
Edwards Lifesciences forecasts 2026 profit above estimates on heart devices strength
Edwards Lifesciences gains on upbeat 2026 profit outlook
Edwards Lifesciences' Q4 revenue beats estimates, partly helped by TMTT sales
Brief: Edwards Says Co Will Not Acquire Jenavalve
US FTC wins ruling blocking Edwards Lifesciences' acquisition of JenaValve (updated)
FTC wins ruling blocking Edwards Lifesciences' acquisition of JenaValve
Medtech: Clear split between gainers and losers in 2025
Brief: FDA Approves Edwards Lifesciences' Sapien M3 Mitral Valve Replacement System As First Transseptal Transcatheter Therapy
U.S. RESEARCH ROUNDUP- Autozone, Coursera, Lennar
U.S. RESEARCH ROUNDUP-Airbnb, Garrett Motion, Range Resources
Brief: Edwards Lifesciences Reaffirms Strategy For Sustainable, Differentiated Growth At Annual Investor Conference
U.S. RESEARCH ROUNDUP- Crowdstrike, Guardant Health, Palantir Technologies
U.S. RESEARCH ROUNDUP- Amazon, Apple, Cigna
Brief: Edwards Lifesciences Announces CFO Transition Plan
Edward Lifesciences rises after quarterly results beat estimates